Jeffrey W. Sherman - Oct 3, 2023 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role
Director
Signature
/s/ Jennifer Johansson, Attorney-in-fact
Stock symbol
LRMR
Transactions as of
Oct 3, 2023
Transactions value $
$0
Form type
4
Date filed
10/5/2023, 04:33 PM
Previous filing
Sep 7, 2023
Next filing
Oct 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRMR Stock Option (Right to Buy) Award $0 +16.6K $0.00 16.6K Oct 3, 2023 Common Stock 16.6K $3.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments over 36 months commencing on November 3, 2023, subject to the Reporting Person's continued service on the Board of Directors of the Company through each applicable vesting date.